Ester Falconer, Chief Technology Officer at AbCellera Biologics Inc. (ABCL), sold 1,000,000 shares at $25.50 ($25.5M) on 2021-06-09, disclosed to the SEC on 2021-06-10.
Open-market sale of $25.5M ABCL by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.